Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Ratings
Exelixis’s Growth Potential Highlighted by Promising STELLAR-002 Trial Results and Buy Rating
9d ago
EXEL
Premium
Ratings
Promising Outlook for Exelixis: Buy Rating Backed by Zanzalintinib’s Efficacy and Anticipated Phase III Trial Success
9d ago
EXEL
Premium
The Fly
Exelixis announces results from expansion cohort of STELLAR-002 trial
9d ago
EXEL
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
15d ago
INM
XLO
Premium
Company Announcements
Exelixis Q1 2025 Earnings Call Highlights Growth
16d ago
EXEL
Premium
The Fly
Exelixis price target raised to $45 from $42 at Guggenheim
16d ago
EXEL
Premium
The Fly
Exelixis price target raised to $56 from $45 at Citi
17d ago
EXEL
Premium
Ratings
Exelixis: Hold Rating Amid Strong Revenue and Uncertain Prospects
17d ago
EXEL
Premium
The Fly
Exelixis price target raised to $44 from $38 at TD Cowen
17d ago
EXEL
Premium
Ratings
Exelixis: Strong Financial Performance and Growth Potential Justify Buy Rating
18d ago
EXEL
Premium
The Fly
Exelixis price target raised to $47 from $40 at Morgan Stanley
18d ago
EXEL
Premium
The Fly
Exelixis price target raised to $38 from $36 at Stifel
18d ago
EXEL
Premium
Ratings
Exelixis Hold Rating: Strong Performance and Promising Pipeline Balanced by Fair Valuation
18d ago
EXEL
Premium
The Fly
Exelixis price target raised to $46 from $41 at Citizens JMP
18d ago
EXEL
Premium
Ratings
Exelixis: Strong Financial Performance and Market Position Justify Buy Rating
18d ago
EXEL
Premium
Company Announcements
Exelixis Reports Strong Q1 2025 Financial Performance
18d ago
EXEL
Premium
Ratings
Exelixis: Strong Financial Performance and Promising Pipeline Drive Buy Rating
18d ago
EXEL
Premium
Ratings
Exelixis’s Strong Financial Performance and Promising Pipeline Drive Optimistic Outlook and Increased Price Target
18d ago
EXEL
Premium
The Fly
Closing Bell Movers: Exelixis up 6% on earnings beat
18d ago
NU
AEO
Premium
The Fly
Exelixis initiated dose-escalation stage of first human Phase 1 study of XB628
18d ago
EXEL
Premium
The Fly
Exelixis reports Q1 adjusted EPS 62c, consensus 44c
18d ago
EXEL
Premium
The Fly
Exelixis raises FY25 revenue view to $2.25B-$2.35B from $2.15B-$2.25B
18d ago
EXEL
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
